Kansas regulates MAC lists and licenses PBMs, but does not set a reimbursement floor. K.S.A. 40-3830 governs which drugs may go on a MAC list and requires lists to be updated every 7 business days, with a 10-business-day appeal — but it does not require reimbursement at NADAC or above acquisition cost.
The 2022 PBM Licensure Act (S.B. 28) brought PBMs under Insurance Department licensure effective January 1, 2023, but it too is a licensing and conduct law, not a reimbursement-floor law.